Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Smith

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Organic & Biomolecular Chemistry|April 29, 2005
Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of beta-hydroxycarbonyl compoundsChristine Le Sann, Dulce M Munoz, Natalie Saunders, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysisLisa M Peterson, Benjamin R Kipp, Kevin C Halling, et al.
Genes, Chromosomes & Cancer|July 12, 2002
Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancerStacy R Denison, Nicole A Becker, Matthew J Ferber, et al.
Clinical Chemistry|July 27, 2002
Host genetic polymorphism analysis in cervical cancerEric S Calhoun, Renee M McGovern, Carol A Janney, et al.
Oncogene|February 20, 2004
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinomaJin-Ping Lai, Jeremy Chien, Scott E Strome, et al.
Human Molecular Genetics|November 17, 2007
Long, abundantly expressed non-coding transcripts are altered in cancerDamon S Perez, Tiffany R Hoage, Jay R Pritchett, et al.
Oncogene|January 13, 2004
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancerJeremy Chien, Julie Staub, Shou-Ih Hu, et al.
The Journal of Biological Chemistry|April 11, 2003
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancerJinping Lai, Jeremy Chien, Julie Staub, et al.
Clinical Endocrinology|August 11, 2017
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceBryan McIver, Stefan K G Grebe, Liang Wang, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Parkin gene alterations in hepatocellular carcinomaFang Wang, Stacy Denison, Jin-Ping Lai, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Organic & Biomolecular Chemistry|April 29, 2005
Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of beta-hydroxycarbonyl compoundsChristine Le Sann, Dulce M Munoz, Natalie Saunders, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysisLisa M Peterson, Benjamin R Kipp, Kevin C Halling, et al.
Genes, Chromosomes & Cancer|July 12, 2002
Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancerStacy R Denison, Nicole A Becker, Matthew J Ferber, et al.
Clinical Chemistry|July 27, 2002
Host genetic polymorphism analysis in cervical cancerEric S Calhoun, Renee M McGovern, Carol A Janney, et al.
Oncogene|February 20, 2004
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinomaJin-Ping Lai, Jeremy Chien, Scott E Strome, et al.
Human Molecular Genetics|November 17, 2007
Long, abundantly expressed non-coding transcripts are altered in cancerDamon S Perez, Tiffany R Hoage, Jay R Pritchett, et al.
Oncogene|January 13, 2004
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancerJeremy Chien, Julie Staub, Shou-Ih Hu, et al.
The Journal of Biological Chemistry|April 11, 2003
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancerJinping Lai, Jeremy Chien, Julie Staub, et al.
Clinical Endocrinology|August 11, 2017
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceBryan McIver, Stefan K G Grebe, Liang Wang, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Parkin gene alterations in hepatocellular carcinomaFang Wang, Stacy Denison, Jin-Ping Lai, et al.
Pageof 11